08.14.26 -- Multispecific Manufacturability Starts With Molecular Design

Explore how to develop a strong packaging system, and learn more about why a reliable supply chain is critical for drug substance and drug product transport.

Evaluating quality frameworks requires balancing immediate compliance with long-term scalability. Learn to analyze organizational maturity and regulatory demands to select an optimal system.

Gain insight into how strategic decisions around equipment are enabling teams to manage complexity, improve scalability, and advance therapies without compromising financial sustainability.

See how early material generation strategies can accelerate development, streamline process optimization, and enable scalable material supply from the earliest stages of development.

Decoding immune cell interactions reveals critical insights for cancer therapy. Advanced imaging and spectral analysis enable precise identification of synapses, accelerating immuno-oncology research.

Discover a modeling approach employing artificial neural networks using experimental factors combined with simulation-derived parameters plus viscosity data from 27 highly concentrated mAbs.

Examine strategies for scaling MSC manufacturing while mitigating biological and operational risks. Learn how closed-system platforms and optimized workflows accelerate the path to commercial cell therapy.

Even well-funded lab informatics environments can leave scientists managing manual handoffs. The real bottleneck often sits between systems, where disconnected workflows slow R&D progress.

Accurate TOC results shouldn’t depend on sample order. Observe how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

Delve into how to choose and validate normalization strategies for western blots, avoid common pitfalls, and ensure reproducible results using proteins tailored to your experimental context.

Cell therapies are revolutionizing cancer care, but their complex manufacturing and high costs bar access for many patients. Automation is emerging as an efficacious solution to reach patients in need.

Begin your ADC manufacturing journey by finding a partner who can provide support through every phase of the conjugate life cycle, including process optimization, scale-up, and validation.